PATENT CLAIM ANALYSIS

Application Number: 15780030
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "348000"]

Abstract:
A method for treating one or more symptoms of COPD comprising administering to an in need of treatment a therapeutically effect amount of one or more mitochondrial iron chelators. The mitochondrial iron chelator can be deferiprone. Compostions comprising mitochondrial iron chelators suitable for administration are also disclosed.

Claim (Index 8):
The method of  claim 1 , wherein the composition does not contain any other iron chelator.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.38889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15209261', '15618075', '14402607', '10069923', '14653245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7033890576564139
- 35 USC 102 Novelty (BERT): 0.5200539824212855
- Combined Prediction Score: 0.6850555501329011
- Mean Citation Score: 181.035348
- Max Citation Score: 220.13805
- Similarity Product: 124.91145527620016

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test